Uploaded April 2022 | Updated September 2026, 2 weeks ago

---

What is the future of diabetes? A century ago, a diabetes diagnosis was a death sentence. With the discovery of insulin, patients suffering from the disease saved. Since this time, millions of lives have been saved and improved. But what’s next? The Co-Founders of Locemia – the Montreal-based company that developed Nasal Glucagon for treating severe low blood sugar – will discuss their personal commitment going forward to supporting other startup company founders driving technologies forward that can help prevent severe low blood sugar before it ever occurs. Don’t miss this second talk in the thematic series “Beyond Injections: 100 years of insulin and the future of diabetes”.

The descriptive transcript can be found here: ingeniumcanada.org/sites/default/files/2022-03/Descriptive-Transcript-driving-innovation-for-insulin-users.pdf

The French version of this video can be found here: youtube.com/watch?v=9ba3OCOktuE

----------------------------------------
CONNECT WITH US!
Facebook: facebook.com/SciTechMuseum
Twitter: twitter.com/SciTechMuseum
Instagram: instagram.com/SciTechMuseum
LinkedIn: linkedin.com/company/ingeniumcanada
----------------------------------------